Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study

BACKGROUND: Denosumab treatment for up to 8 years in the FREEDOM study and Extension was associated with low fracture incidence. It was not clear whether subjects who discontinued during the study conduct had a higher risk of fracture than those who remained enrolled, thereby underestimating the tru...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Musculoskelet Disord
Autors principals: Adachi, Jonathan D., Bone, Henry G., Daizadeh, Nadia S., Dakin, Paula, Papapoulos, Socrates, Hadji, Peyman, Recknor, Chris, Bolognese, Michael A., Wang, Andrea, Lin, Celia J. F., Wagman, Rachel B., Ferrari, Serge
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5408481/
https://ncbi.nlm.nih.gov/pubmed/28449657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-017-1520-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars